• 

  05.21.13

  Commonly used catheters double risk of blood clots in ICU and cancer patients

  U-M study finds peripherally inserted central catheters - an often preferred route for delivery of IV medications - increase risk of blood clots in sickest patients.

  Touted for safety, ease and patient convenience, peripherally inserted central catheters have become many clinicians' go-to for IV delivery of antibiotics, nutrition, chemotherapy, and other medications.

  But compared to other central venous catheters (CVCs), these commonly-used catheters (known as PICCs) more than double the risk of dangerous blood clots - especially among patients who are critically ill or who have cancer.
• 

  05.17.13

  Decoded: Molecular messages that tell prostate and breast cancers to spread

  Cancer cells are wily, well-traveled adversaries, constantly side-stepping treatments to stop their spread.

  But for the first time, scientists at the University of Michigan have decoded the molecular chatter that ramps certain cancer cells into overdrive and can cause tumors to metastasize throughout the body.

  Español        |        Português
• 

  05.08.13

  Study finds gaps in "decision aids" designed to help determine right cancer screening option for patients

  When it comes to a cancer diagnosis, timing can be everything – the sooner it's found, the more treatable it is. But when and how often should someone get screened?

  A growing number of educational, interactive tools known as "decision aids" – such as videodiscs, audiotapes, workbooks and pamphlets – are intended to supplement patient-doctor discussions on the pros and cons of timing, methods and frequency for different types of cancer screening.

More 2013 releases